Form 4: Lam Research Executive Christina Correia Sells 647 Shares Under 10b5-1 Plan
SEC Form 4
Christina Correia, CVP and Chief Accounting Officer of Lam Research, sold 647 shares of common stock at a price of $972.03 per share on April 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On April 1, 2024, Christina Correia, the CVP and Chief Accounting Officer of Lam Research, sold 647 shares of the company's common stock.
- The sale was executed at a price of $972.03 per share.
- This transaction was conducted under a Rule 10b5-1 trading plan that was adopted on August 4, 2023.
- Following the transaction, Correia directly owns 5,541 shares of Lam Research, including unvested restricted stock units.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports a routine stock sale under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment towards the company's prospects.
Industry Context
Insider transactions are routinely monitored and reported to the SEC. Sales under 10b5-1 plans are common and allow insiders to sell shares at predetermined times to avoid accusations of trading on inside information.
Stakeholder Impact
- The sale of shares by an executive could be perceived neutrally or slightly negatively by shareholders, but the existence of a 10b5-1 plan mitigates concerns about insider information.
Key Dates
| Date | Description |
|---|---|
| 08/04/2023 | Date the reporting person adopted the Rule 10b5-1 trading plan |
| 04/01/2024 | Date of the transaction (stock sale) |
| 04/02/2024 | Date of the signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.